Prescription drug · NDA AUTHORIZED GENERIC
Triamterene NDC 66993-832
Triamterene 100 mg/1 · Capsule · Oral · Prasco Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66993-832-02 | 6699308320266993083202 | 100 CAPSULE in 1 BOTTLE (66993-832-02)Marketed from Aug 13, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Triamterene
- Generic name (nonproprietary)
- triamterene
- Active ingredients
- Triamterene — 100 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Prasco LaboratoriesNDC labeler code 66993
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 013174
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Renal K+ Excretion (Physiologic effect)Increased Diuresis (Physiologic effect)
- Identifiers
- Product ID 66993-832_d7ce0a55-ba61-4995-8141-43c4736d4be9SPL ID d7ce0a55-ba61-4995-8141-43c4736d4be9SPL set ID a09c2212-1dd5-4fbe-ad09-2a57aeabcaeaRxCUI 198312, 198313UNII WS821Z52LQUPC 0366993831022
- Pharmacologic class
- Potassium-sparing Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466993083202followed by a unit qualifier and the quantityPackage 66993-0832-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Triamterene capsules are indicated in the treatment of edema associated with congestive heart failure, cirrhosis of the liver and the nephrotic syndrome; steroid-induced edema, idiopathic edema and edema due to secondary hyperaldosteronism. Triamterene capsules may be used alone or with other diuretics, either for its added diuretic effect or its potassium-sparing potential. It also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism. Usage in Pregnancy . The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unn…
Excerpt only. Read the full label for complete information.
About NDC 66993-832
- What is NDC 66993-832?
- 66993-832 is the product NDC for Triamterene, Triamterene 100 mg/1 capsule, listed with the FDA by Prasco Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Triamterene.
- What is the active ingredient?
- Triamterene.
- Who is the labeler?
- Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Triamterene?
- 6 other product NDCs are listed under this name. See all Triamterene NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Triamterene products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Triamterene | Triamterene 50 mg/1 | CapsuleOral | Biocon Pharma Inc. | 70377-138 | 70377-0138-1170377-0138-12 |
| Triamterene | Triamterene 100 mg/1 | CapsuleOral | Biocon Pharma Inc. | 70377-139 | 70377-0139-1170377-0139-12 |
| triamterene | Triamterene 50 mg/1 | CapsuleOral | Prasco Laboratories | 66993-831 | 66993-0831-02 |
| Triamterenetriamterene capsules | Triamterene 50 mg/1 | CapsuleOral | TRUPHARMA LLC | 52817-364 | 52817-0364-10 |
| Triamterenetriamterene capsules | Triamterene 100 mg/1 | CapsuleOral | TRUPHARMA LLC | 52817-365 | 52817-0365-10 |
| Triamterenetriamterene capsules | Triamterene 50 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-2265 | 72162-2265-01 |
Other NDCs under NDA 013174
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dyreniumtriamterene | Triamterene 50 mg/1 | CapsuleOral | Advanz Pharma (US) Corp. | 59212-002 |
| Dyreniumtriamterene | Triamterene 100 mg/1 | CapsuleOral | Advanz Pharma (US) Corp. | 59212-003 |
| triamterene | Triamterene 50 mg/1 | CapsuleOral | Prasco Laboratories | 66993-831 |